MiniMed Group Inc.
MMED | NASDAQ
$18.80
+$0.52 (+2.84%)
Nov 2, 2026, 12:20 PM ET · Market open
Fiscal Quarter Period Ending | Q1 2026 Jul 31, 2026 | Q4 2025 Apr 24, 2026 | Q3 2025 Jan 31, 2026 | Q2 2025 Oct 31, 2025 | Q4 2024 Apr 30, 2025 |
|---|---|---|---|---|---|
Revenue | 843M | 837M | 790M | 752M | 724M |
Cost of Revenue | 378M | 357M | 428M | 324M | 321M |
Gross Profit | 465M | 480M | 362M | 428M | 402M |
Operating Income | 38M | 82M | -93M | -10M | -204M |
Interest Income | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 4M | -90M | -99M | -12M | -204M |
Net Income | n/a | -183M | -119M | -27M | -209M |
Selling & General & Admin | 312M | 299M | 309M | 318M | 327M |
Research & Development | 115M | 99M | 114M | 111M | 109M |
Other Expenses | n/a | n/a | 32M | 9M | 171M |
Operating Expenses | 427M | 398M | 455M | 438M | 607M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 309M | n/a | 327M |
Cost & Expenses | 805M | 755M | 883M | 762M | 928M |
Income Tax Expense | 4M | 93M | 12M | 19M | 17M |
Shares Outstanding (Basic) | 281M | 268.1M | 280.81M | n/a | n/a |
Shares Outstanding (Diluted) | 281M | 268.1M | 280.81M | n/a | n/a |
EPS (Basic) | n/a | -0.68 | -0.42 | n/a | n/a |
EPS (Diluted) | n/a | -0.68 | -0.42 | n/a | n/a |
EBITDA | 38M | 82M | -60M | 29M | n/a |
EBIT | 38M | 82M | -99M | -10M | -38M |
Depreciation & Amortization | n/a | n/a | 39M | 39M | 38M |
Add to Watchlist
Select watchlists to add or remove MMED